Survival of women after breast conserving surgery for early stage breast cancer
- PMID: 12000218
- DOI: 10.1023/a:1014908802632
Survival of women after breast conserving surgery for early stage breast cancer
Abstract
Background: Increasing numbers of older women with breast cancer are receiving breast-conserving surgery (BCS). However, substantial numbers of them are not receiving either axillary dissection or adjuvant irradiation.
Objective: To determine whether failure to perform axillary dissection or irradiation is associated with decreased survival in women with early-stage breast cancer.
Method: We studied 26,290 women aged > or = 25 in 1988-1993 from the surveillance, epidemiology, and end results (SEER) data and 5,328 women aged > or = 65 in 1991-1993 from SEER-Medicare linked data, who had early-stage breast cancer and received BCS.
Results: Twenty seven percent of women aged > or = 25 receiving BCS did not receive axillary dissection, most of whom (74%) were age > or = 65. Women receiving BCS with axillary dissection had lower 7-year breast cancer-specific mortality than did those without dissection (hazard ratio = 0.53, 95% confidence interval: 0.44-0.63). We found an interaction between receipt of axillary dissection and radiotherapy on survival of older women after BCS. Women who received either axillary dissection or radiotherapy experienced similar survivals to those who received both axillary dissection and radiation, while women who received neither treatment experienced poorer survival (hazard ratio = 1.76, 1.23-2.52), after controlling for demographics, tumor size and comorbidity.
Conclusions: Women who receive neither axillary dissection nor radiation therapy after BCS experience an increased risk of death from breast cancer. The lack of improvement in the past two decades in survival of older women with breast cancer may be explained in part by the increasing use of treatments that do not address potential tumor in axillary nodes.
Similar articles
-
Disparities in breast cancer treatment and survival for women with disabilities.Ann Intern Med. 2006 Nov 7;145(9):637-45. doi: 10.7326/0003-4819-145-9-200611070-00005. Ann Intern Med. 2006. PMID: 17088576 Free PMC article.
-
Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival.J Am Coll Surg. 1999 Jun;188(6):586-95; discussion 595-6. doi: 10.1016/s1072-7515(99)00056-3. J Am Coll Surg. 1999. PMID: 10359351
-
Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):658-70. doi: 10.1016/s0360-3016(03)00017-8. Int J Radiat Oncol Biol Phys. 2003. PMID: 12788171
-
[Management of the axilla in breast cancer: evidences and unresolved issues].Orv Hetil. 2001 Sep 9;142(36):1941-50. Orv Hetil. 2001. PMID: 11680099 Review. Hungarian.
-
The surgical management of primary invasive breast cancer.CA Cancer J Clin. 1995 Sep-Oct;45(5):279-88. doi: 10.3322/canjclin.45.5.279. CA Cancer J Clin. 1995. PMID: 7656131 Review.
Cited by
-
Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series.Radiat Oncol. 2011 Mar 17;6:25. doi: 10.1186/1748-717X-6-25. Radiat Oncol. 2011. PMID: 21414215 Free PMC article.
-
Investigating confounders of the association between survival and adjuvant radiation therapy after breast conserving surgery in a sample of elderly breast Cancer patients in Appalachia.BMC Cancer. 2019 Dec 17;19(1):1228. doi: 10.1186/s12885-019-6263-3. BMC Cancer. 2019. PMID: 31847855 Free PMC article.
-
Comorbid disease and cancer: the need for more relevant conceptual models in health services research.J Clin Oncol. 2005 Oct 20;23(30):7399-404. doi: 10.1200/JCO.2004.00.9753. J Clin Oncol. 2005. PMID: 16234509 Free PMC article. Review. No abstract available.
-
Racial differences in patterns of care among medicaid-enrolled patients with breast cancer.J Oncol Pract. 2006 Sep;2(5):205-13. doi: 10.1200/JOP.2006.2.5.205. J Oncol Pract. 2006. PMID: 20859339 Free PMC article.
-
Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery.Cancers (Basel). 2024 Sep 27;16(19):3317. doi: 10.3390/cancers16193317. Cancers (Basel). 2024. PMID: 39409937 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous